Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

Tolaney, Sara M.; Nechushtan, Hovav; Ron, Ilan-Gil; Schöffski, Patrick; Awada, Ahmad; Yasenchak, Chris A.; Laird, A. Douglas; O’Keeffe, Bridget; Shapiro, Geoffrey I.; Winer, Eric P.

期刊名称Breast Cancer Research and Treatment
作者Tolaney, Sara M.; Nechushtan, Hovav; Ron, Ilan-Gil; Schöffski, Patrick; Awada, Ahmad; Yasenchak, Chris A.; Laird, A. Douglas; O’Keeffe, Bridget; Shapiro, Geoffrey I.; Winer, Eric P.
卷第160卷
期第2期
印刷ISSN0167-6806
电子ISSN1573-7217
文件大小515.73KB
发表时间2016-11-6
DOI10.1007/s10549-016-4001-y
页码305-312

发现好书期刊，享受阅读乐趣

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study